Molecular Pharmacology 2010-10-01

Mind your salts: when the inactive constituent isn't.

Richard R Neubig

Index: Mol. Pharmacol. 78(4) , 558-9, (2010)

Full Text: HTML

Abstract

Many pharmacological agents include "inactive" constituents that are used to alter the solubility, stability, or pharmaceutical properties of a drug. These "salts" are often ignored, and the "active ingredient" gets all of the attention. Pamoic acid (4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid) has been used in formulations of several drugs as pamoate salts. This Perspective highlights an Accelerated Communication in this issue (p. 560) that identifies pamoic acid as a potent activator of the orphan G protein-coupled receptor GPR35. This effect may contribute to the pharmacological actions of some agents that are prepared as pamoate salts. Thus, pharmacologists, regulators, and clinicians should "mind their salts" in considering differences among supposedly equivalent agents.

Related Compounds

  • Pamoic acid

Related Articles:

Long-acting atypical antipsychotics: characterization of the local tissue response.

2014-08-01

[Pharm. Res. 31(8) , 2065-77, (2014)]

Identification of small-molecule antagonists that inhibit an activator: coactivator interaction.

2004-12-21

[Proc. Natl. Acad. Sci. U. S. A. 101 , 17622-17627, (2004)]

Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation.

2013-01-07

[Mol. Pharm. 10(1) , 319-28, (2013)]

Identification and purity determination of benzathine and embonate salts of some beta-lactam antibiotics by thin-layer chromatography.

[J. Chromatogr. A. 463(2) , 469-73, (1989)]

Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.

2004-09-17

[J. Biol. Chem. 279(38) , 39736-44, (2004)]

More Articles...